Page 109 - NobleCon19revC2_Neat

Helius Medical Technologies, Inc.

SELECTED FINANCIAL ITEMS HSDT

(in millions of USD)
CQ4 '22 CQ1 '23 CQ2 '23 CQ3 '23 LTM
Income Statement Key Items
Total Revenue 0.28 0.11 0.26 0.14 0.79
Gross Profit 0.13 (0.01) 0.07 (0.04) 0.15
Gross Margin 47% -10% 28% -31% 19%
EBIT (2.67) (3.81) (3.22) (2.99) (12.69)
EBIT Margin -946% -3432% -1257% -2094% -1603%
Net Income to Common Shareholders (4.89) (2.49) (1.65) (3.66) (12.69)
Net Margin -1733% -2247% -644% -2562% -1602%

Balance Sheet Key Items
Total Assets 17.29 13.76 10.75 8.85 8.85
Cash & Short Term Investments 14.55 11.34 8.60 6.60 6.60
% of Assets 84% 82% 80% 74% 74%
Current Assets -Total 16.70 13.21 10.27 8.58 8.58
% of Assets 97% 96% 95% 97% 97%
Total Liabilities 9.14 7.69 6.18 5.83 5.83
% of Assets 53% 56% 57% 66% 66%
Current Liabilities - Total 1.99 1.79 1.52 1.44 1.44
% of Assets 11% 13% 14% 16% 16%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 8.15 6.07 4.57 3.02 3.02
% of Assets 47% 44% 43% 34% 34%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (2.14) (3.19) (2.74) (2.45) (10.53)
Net Cash Flow - Investing 0.00 (0.02) (0.00) (0.01) (0.02)
Net Cash Flow - Financing 0.00 NA NA 0.46 0.46

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference